Synapse

  • About
  • FAQ
  • Reports
  • Contact Us
  • Memorial Sloan Kettering Cancer Center

  • Works
  • Groups
  • People
  • Publications
  • Publishers
  • In Press
Advanced

1 Result

People

  1. Campos
    Campos
  2. Codega
    Codega
  3. Mellinghoff
    Mellinghoff

Groups

  1. GSK Faculty (1)
  2. Human Oncology and Pathogenesis Program (1)
  3. Sloan Kettering Institute Postdocs (1)
  4. Tow Center for Developmental Oncology (TCDO) (1)
  1. "mutant idh1/midh2"
Formats
  1. Research Letter (1)
Groups
  1. GSK Faculty (1)
  2. Human Oncology and Pathogenesis Program (1)
  3. Sloan Kettering Institute Postdocs (1)
  4. Tow Center for Developmental Oncology (TCDO) (1)
People
  1. Carl Campos (1)
  2. Ingo Mellinghoff (1)
  3. Paolo Codega (1)
Years
  1. 2020 (1)
Publications
  1. ACS Medicinal Chemistry Letters (1)
Publishers
  1. American Chemical Society (1)

Results (1)

Export to EndNote / Excel

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vorasidenib (AG-881): A first-in-class, brain-penetrant dual inhibitor of mutant IDH1 and 2 for treatment of glioma
    Research Letter

    Konteatis, Z.; Artin, E.; Nicolay, B.; Straley, K.; Padyana, A. K.; Jin, L.; Chen, Y.; Narayaraswamy, R.; Tong, S.; Wang, F.; more...
    ACS Medicinal Chemistry Letters (2020)

    Fulltext@MSK | Save
  • Follow Us on
    Memorial Sloan Kettering Cancer Center | Memorial Hospital for Cancer and Allied Diseases | Sloan Kettering Institute
    Gerstner Sloan Kettering Graduate School of Biomedical Sciences Patients & Caregivers

    Legal Disclaimer | Giving to the Library
    © 2022 Memorial Sloan Kettering Cancer Center Library